GT Biopharma (GTBP) Common Equity (2010 - 2026)
GT Biopharma (GTBP) reported Common Equity of $7.58 million for Q1 2026, compared with -$980,000 a year earlier and up 31.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma posted Common Equity of $5.79 million.
- By year, Common Equity came in at -$1.67 million in FY2024, $7.48 million in FY2023 (-36.3%), $11.73 million in FY2022 (-46.4%) and $21.91 million in FY2021.
- The Q1 2026 figure ranks as the highest quarterly Common Equity since Q3 2023.
- The high point for year-over-year Common Equity in five years was Q3 2025 (growth of 43.1%); the low point was Q3 2024 (a decline of 79.0%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $5.79 million (Q4 2025), $3 million (Q3 2025) and -$25.88 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | GT Biopharma | 9.57 Mn | 9.57 Mn | - | 7.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7.58 Mn |
| Dec 31, 2025 | 5.79 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | -25.88 Mn |
| Mar 31, 2025 | -980,000.00 |
| Dec 31, 2024 | -1.67 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 7.48 Mn |
| Sep 30, 2023 | 10.01 Mn |
| Jun 30, 2023 | 11.76 Mn |
| Mar 31, 2023 | 13.05 Mn |
| Dec 31, 2022 | 11.73 Mn |
| Sep 30, 2022 | 15.95 Mn |
| Jun 30, 2022 | 15.44 Mn |
| Mar 31, 2022 | 17.79 Mn |
| Dec 31, 2021 | 21.91 Mn |
| Sep 30, 2021 | 31.88 Mn |
| Jun 30, 2021 | 36.29 Mn |
API Access
GT Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();